We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.33B
AUM Growth
+$70.1M
Cap. Flow
-$89.7M
Cap. Flow %
-3.85%
Top 10 Hldgs %
23.05%
Holding
203
New
5
Increased
30
Reduced
65
Closed
11

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$12.8M
2
IQV icon
IQVIA
IQV
+$8.32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.79M
4
POOL icon
Pool Corp
POOL
+$7.16M
5
DVN icon
Devon Energy
DVN
+$6.82M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$29.3M
2
ACGL icon
Arch Capital
ACGL
+$24.2M
3
NEE icon
NextEra Energy
NEE
+$11.7M
4
FISV
Fiserv Inc
FISV
+$8.96M
5
ECL icon
Ecolab
ECL
+$6.6M

Sector Composition

Rank Sector Weight
1 Technology 33.52%
2 Industrials 18.51%
3 Financials 15.9%
4 Healthcare 15.48%
5 Consumer Discretionary 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
201
Target
TGT
$65.6B
-17,018
Closed -$2.52M
ZWS icon
202
Zurn Elkay Water Solutions
ZWS
$8.38B
-41,000
Closed -$1M
AJRD
203
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-31,000
Closed -$1.24M

Similar funds

EULAV Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, EULAV Asset Management held 203 positions worth $2.33B, up 3.1% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

EULAV Asset Management withdrew a net $89.7M in Q4 2022, closing 11 positions and reducing 65 holdings. Its most notable exit was Arch Capital, an estimated $24.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.

Against the trend, EULAV Asset Management opened a new position in BioMarin Pharmaceuticals worth $8.59M.

  • EULAV Asset Management's largest Q4 2022 buy was BioMarin Pharmaceuticals: 83,000 shares worth $8.59M.
  • EULAV Asset Management added most to Idexx Laboratories in Q4 2022, an estimated $12.8M increase.
  • EULAV Asset Management's biggest Q4 2022 reduction was Danaher, cutting an estimated $29.3M.
  • EULAV Asset Management fully exited Arch Capital in Q4 2022, selling an estimated $24.2M.
  • EULAV Asset Management's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2022.
  • EULAV Asset Management opened 5 new positions and closed 11 in Q4 2022.
  • EULAV Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.33B.

Based on EULAV Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.